Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Phibro Animal Health (PAHC) Gross Profit (2016 - 2025)

Phibro Animal Health (PAHC) has 13 years of Gross Profit data on record, last reported at $132.7 million in Q4 2025.

  • For Q4 2025, Gross Profit rose 30.22% year-over-year to $132.7 million; the TTM value through Dec 2025 reached $467.0 million, up 32.63%, while the annual FY2025 figure was $399.9 million, 27.74% up from the prior year.
  • Gross Profit reached $132.7 million in Q4 2025 per PAHC's latest filing, up from $119.8 million in the prior quarter.
  • Across five years, Gross Profit topped out at $132.7 million in Q4 2025 and bottomed at $64.7 million in Q3 2021.
  • Average Gross Profit over 5 years is $84.4 million, with a median of $77.9 million recorded in 2022.
  • Peak YoY movement for Gross Profit: fell 2.24% in 2023, then surged 43.46% in 2025.
  • A 5-year view of Gross Profit shows it stood at $70.7 million in 2021, then increased by 9.5% to $77.4 million in 2022, then grew by 1.59% to $78.6 million in 2023, then increased by 29.58% to $101.9 million in 2024, then surged by 30.22% to $132.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Gross Profit were $132.7 million in Q4 2025, $119.8 million in Q3 2025, and $110.0 million in Q2 2025.